Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Haerbin
Clinical trial register · China

Clinical Trials in Haerbin, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19398 matching records held by the registry are in this view. Synced 20 Nov 2026, 03:17 UTC
19398
Studies in scope
all four open statuses
11919
Recruiting now
open to new participants
2037
Lead sponsors
across recruiting studies
Top sites
Beijing 5634 Shanghai 3911 Guangzhou 3374 Hangzhou 1834 Wuhan 1350
Narrow the registerReset
Recruitment status
Phase
Site location
Beijing5634 Shanghai3911 Guangzhou3374 Hangzhou1834 Wuhan1350 Chengdu1314 Nanjing1217 Changsha1164 Chongqing1086 Fuzhou1046 Tianjin944 Zhengzhou931 Hefei908 Jinan798 Changchun642 Shenzhen585 Harbin548 Nanchang449 Xi'an449 Nanning444 Suzhou434 Shenyang411 Xiamen391 Shijiazhuang351 Lanzhou276 Bengbu218 Kunming189 Wenzhou189 Guiyang184 Qingdao175 Luoyang161 Ningbo152 Taiyuan152 Foshan145 Dalian135 Xuzhou134 Haikou126 Changzhou124 Dongguan108 Shantou102 Hong Kong100 Nantong99 Wuhu93 Wuxi85 Huizhou84 Baoding84 Anyang83 Baotou82 Zhuhai79 Guangdong76 Liuzhou72 Xi’an71 Cangzhou64 Zhongshan60 Ganzhou60 Hohhot59 Xinxiang58 Taizhou55 Yangzhou55 Guilin54 Jiangmen53 Ürümqi53 Yiwu53 Guanzhou51 Yinchuan48 Zunyi47 Linyi47 Zhejiang47 Zhanjiang47 Fuyang47 Zhangzhou46 Meizhou46 Nanyang45 Quanzhou45 Huzhou43 Lishui43 Jinhua43 Changde42 Hanzhou42 Langfang40 Huai'an39 Jining38 Jiaxing37 Fujian36 Tangshan36 Jilin City34 Xiangyang32 Henan31 Hunan31 Kaifeng31 Daqing30 Xining30 Binzhou30 Chifeng29 Yantai28 Shandong28 Yichang27 Hengyang27 Chengde27 Changzhi27 Xingtai26 Sichuan26 Shiyan25 Jingzhou25 Hubei25 Xianyang24 Weifang23 Mianyang23 Wuzhou23 Hebei22 Wuwei22 Haerbin21 Nanchong21 Lianyungang20 Jiamusi20 Shaoguan20 Luzhou20 Shanxi19 Deyang19 Zhenjiang19 Liaocheng18 Putian18 Bozhou18 Chenzhou18 Anqing18 Yancheng18 Shaoxing17 Qingyuan16 Quzhou16 Qinhuangdao16 Handan16 Xian15 Zibo15 Chizhou15 Yulin15 Luoyang Shi14 Maoming14 Guangxi14 Shangqiu14 Pingxiang13 Ha’erbin13 Haidian13 Heilongjiang13 Guizhou13 Xiangtan13 Jiaozuo12 Zhenzhou12 Shengyang12 Dongyang12 Beijin11 Chaoyang11 Guandong11 Ma’anshan11 Suqian11 Nanjin11 Kunshan11 Huaian11 Jiujiang11 Yan’an11 Huanggang10 Heyuan10 Ankang10 Zhuzhou10 Jieyang10 Qionghai10 Tianjing10 Baise City10 Linfen10 Longyan10 Hengshui9 Hanzhong9 Chuzhou9 Heze9 Guigang9 Tongling9 Neijiang9 Weinan9 Zhangjiakou8 Zigong8 Huaihua8 Tai’an8 Xicheng8 Zhoukou8 Jiangxi8 Yueyang8 Liupanshui8 Zhaoqing8 Qinzhou8 Shaoyang8 Linhai8 Cheng Du Shi7 Ch’ang-ch’un7 Huainan7 Fuzhou Fujian7 Sanming7 Shenzhen Shi7 Anhui7 Dezhou7 Sanya7 Jinjiang7 Dongying7 Hainan7 Lu'an7 Yibin7 Xuchang7 Baoji7 Dali7 Shanghai Shi6 Huangshi6 Xuhui6 Kaili6 Zhoushan6 Kashgar6 Naning6 Chaoyang District6 Xuancheng6 Luohe6 China6 Zhumadian6 Suining6 Dazhou6 Jinzhou6 Puyang6 Meihekou6 Qianjiang5 Jiazhuang5 Dongcheng5 Macao5 Changping5 Wanzhou5 Panjin5 Mudanjiang5 Haidian District5 Tongliao5 Shihezi5 Yixing5 Lanxi5 Yuhuan5 Bijie5 Enshi5 Changshu5 Anshan5 Datong5 Yuncheng5 Yuzhong5 Ji'nan4 Suzhu4 Pudong4 Benxi4 Ningde4 Chendu4 Jiuquan4 Huangpu4 Anning4 Multiple Locations4 Qinghai4 Sanmenxia4 Xianning4 Jiangsu4 Ya'an4 Jingdezhen4 Taian4 Wenling4 Huangshan City4 Jiangyin4 Qiqihar4 Weihai4 Yongzhou4 Hezhou4 Chaohu4 Gaozhou4 Changsha Shi3 Yunfu3 Zhujiang3 Dengzhou3 Shanwei3 Yanan3 Yangjiang3 Shunde3 Guankou3 Ji’an3 Aksu3 Xinjiang3 Beihai3 Fushun3 Lhasa3 Hebi3 Shang'ai3 Weihui3 Binhai3 Minhang District3 Loudi3 Chongqicun3 Jingmen3 Dongwan3 Rizhao3 Bishan3 Shapingba3 Yunnan3 Leshan3 Xingyi3 Fuxin3 Anshun3 Zhangjiang3 Gansu3 Jiyuan3 Yangpu3 Huaibei3 Neimeng3 Guangdong Province3 Beijingcun3 Xiantao3 Lincang2 Liangyugang2 Xigazê2 Tongzhou2 Chaozhou2 Huayuan2 Dingxi2 Jiaxin2 Siping2 Inner Mongolia2 Chongqi2 Meicheng2 Gongshu District2 Dangyang2 Guli2 Ninghai2 Baotou Shi2 Karamay2 Nan'ning2 Haozhou2 Jincheng2 Jinzhong2 Taipei2 Maanshan2 Shatin2 Ningxia2 Yixingcun2 Tongren2 Xiaogan2 Guangyuan2 Chuxiong2 Meishan2 Fuling2 Hechuan2 Qiandongnan Miao and Dong Autonomous Prefecture2 Baoshan2 Fengtai2 Panlong2 Xicheng District2 Jing’an2 Shanhai2 Taihe Chengguanzhen2 Anxi2 Xinyang2 Linqing2 Guiping2 Herbin2 Yichun2 Qiannan2 Qujing2 Chibi2 Danyang2 Zaozhuang2 Yisa2 Changlexi2 Xuhui District2 Jishou2 Tianshui2 Jingjiang2 Changzhou Shi2 Hechi2 Taiwan2 Yichang Shi2 Suizhou2 Dandong2 Pingdingshan2 Yiyang2 Many Locations2 Macau2 Changle2 Yueqing2 Rui’an2 Gengma County1 Shijia Zhuang1 Jinghong1 Xiameng1 Hami1 Liu‘an1 Chian1 Gulin1 Hanyang1 Zhuji1 Changning1 Xiangyun1 Chang’an1 Cili1 Lanshan1 Leiyang1 Pingjiang1 Hetian1 Xi'an, China1 Heihe1 Dongfang1 Fu'zhou1 Wuha1 Hengshui Shi1 Guanghzou1 Beijjing1 Kaiping1 Panzhihua1 Beijing, China1 Gannan1 Beiliu1 Guidong1 Hangzou1 Jihan1 Longgang1 Chengdu, Sichuan1 Baiyin1 Xinle1 Hshijiazhuang1 Jiangse1 Zhangye1 Guangong Apt/Yuncheng1 Nnajing1 Bingjie1 Sanjiaocheng1 Jimsar1 Luopu1 Lanfang1 Hexi District1 Puning1 Yanji1 Anji1 Haining1 Linxia1 Xianmencun1 Yuzhong District1 Guangzhusi1 Heifei1 Changhua1 Haizhu1 Zhuozhou1 Zhenngzhou1 Xiangya1 Tongji1 Heping1 Fengcheng1 Gunan1 Jiangjin1 Wulong1 Linping1 Qingzhen1 Hongkou1 Pizhou1 Taishing1 Beijing Sheng1 Jina1 Cangzhou Shi1 Shancheng1 Najing1 Xiangshan1 Yangzhou SHI1 Wuhou District1 Shenyany1 Daping1 Gu'ang'zhou1 Shenzhencun1 Siming1 Fuqing1 Nanping1 Jixi1 Liangshan1 Ziyang1 Luocheng1 Santai1 Sichuan Chengdu1 Dongguan Shi1 Lingchuan1 Xing’an1 Daming1 Dingxing1 Zhengding1 Wenquan1 Ordos1 Zunhua1 Mengzhou1 Nanle1 Ningxiang1 GuiZhou1 HuBei1 HuNan1 Taihe1 Tanjing1 Sanhe1 Linquan County1 Shushan1 Wujin District1 Heifi1 Changshan1 Tiyuan1 Wuhang1 Feixian1 Hexi District, Tianjin1 Jiayuguan1 Zhangping1 Zhaotong1 Puer1 Wenshan1 Wuhai1 Xichengqu Beijing1 Anhui Sheng1 Hubei Sheng1 XI 'an City, Shaanxi Province1 Chengdoucun1 Louxing District1 Guang’an1 Changcun1 Hongcun1 Tacheng1 Maoming Shi1 Fenyang1 Pinggu1 Pu'er1 Jiading1 Guangxi Zhuang Autonomous Region1 Yongcheng1 Yangzhong1 Ulanhot1 Fulingqu1 Chancheng District1 Liwan District1 North Street1 Nanshan District1 Dexing1 Wanzai1 Anning, Yunnan - South Region1 Beijing, Beijing1 Cangzhou, Hebei - North Region1 Caoxian County, Shandong Province1 Changzhou, Jiangsu Province1 Chengdu, Sichuan Province1 Chongqing, Chongqing1 Chongqing, Sichuan Province1 Wenshan Zhuang and Miao Autonomous Prefecture1 Chongli1 Ezhou1 Chongoing1 Liaoyou1 Chengxiang1 Fyzhou1 Nanzhang Chengguanzhen1 Yushu1 Yangcheng1 Ji'an1 Minhang1 Luoyan1 Tainan1 Taoyuan1 Shanhu1 XiAn1 Xizang1 Gui'lin1 Wannan1 Zheng'zhou1 Duyun1 Dazhu1 Dingzhou1 Feicheng1 Pinghu1 Bayan Nur1 Chuangchun1 Binzhou Shi1 Fengning1 Qingpingjie1 Chongzuo1 Laibin1 Tianmen1 Guangdong Province Guangzhou City1 Jianli City, Jingzhou City1 Jingxi1 Tengzhou Town1 Xiangyang City, Hubei Province1 Changshang1 Yizheng1 Junxian1 Pingdu1 Zouping1 Huozhou1 Jiexiu1 Wu’an1 Fuding1 Lianyuan1 Yongji1 Xian City1 Hegang1 Shuangyashan1 Suihua1 Hengzhou1 Laizhou1 Ruyang1 Jining Shi1 Daozhen Klau and Hmong Autonomous County in Zun'yi1 Qiandongnan Miao and Dong Autonomous Region1 Changshashi1 Jiancheng1 Tanjin1 Chongging1 Xinzheng1 Changchuan1 Nayong1 Gongyi1 Shang’ai1 Beijeing1 Deyang Shi1 Foshan Shi1 Lingbao1 Qidong1 Yunlin1 Shangluo1 Yining1 Longzhou1 Zhengjiang1 Qinhuangdao Shi1 Qingyang1 Yingtan1 Yangchun1 Zhangjiagang1 Zhongshan Town1 Tongchuan1
All 632 locations
Target enrolment
to

Trials with a site in Haerbin

21 of 19398 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Hangzhou Sumgen Biotech Co., Ltd.
Phase 1/2
180
Chongqing, Fuzhou, Guanzhou, Chengde, Haerbin, Xinxiang, Changsha, Changchun
2026-09-18
Recruiting
4D Molecular Therapeutics
Phase 3
514
Beijing, Changchun, Changsha, Haerbin, Hangzhou, Jinan, Lanzhou, Nanchang
2026-09-18
Recruiting
AstraZeneca
Observational
2,100
Beijing, Changsha, Chengdu, Guangzhou, Haerbin, Jinan, Nantong, Shanghai
2026-03-06
Active, closed
Tianjin Medical University Second Hospital
Not applicable
360
Xingtai, Guangzhou, Haerbin, Kunming, Nanchang, Tianjin
2025-09-20
Recruiting
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 1
220
Beijing, Haerbin, Zhengzhou, Changsha, Nanjing, Jinan, Shanghai, Chengdu
2025-05-20
Recruiting
Jacobio Pharmaceuticals Co., Ltd.
Phase 1/2
334
Hefei, Beijing, Fuzhou, Guangzhou, Nanning, Langfang, Haerbin, Zhengzhou
2024-11-22
Recruiting
JAB-21822 Combined With JAB-3312 Compared SOC in the First Line for Treatment of Advanced Non-small Cell Lung Cancer With KRAS p.G12C Mutation
NCT06416410Advanced Non-squamous Non-small-cell Lung Cancer, Metastatic Non-squamous Non Small Cell Lung Cancer
Allist Pharmaceuticals, Inc.
Phase 3
392
Hefei, Beijing, Fuzhou, Guangzhou, Shenzhen, Nanning, Cangzhou, Haerbin
2024-08-07
Recruiting
A Study of GFH375 in Patients With Advanced Solid Tumors With KRAS G12D Mutations
NCT06500676KRAS G12D Mutations, Advanced Solid Tumors
Genfleet Therapeutics (Shanghai) Inc.
Phase 1/2
407
Hefei, Beijing, Guangzhou, Nanning, Haerbin, Zhengzhou, Wuhan, Changsha
2024-07-09
Recruiting
Daiichi Sankyo
Phase 3
540
Beijing, Changchun, Changsha, Chengdu, Chongqing, Haerbin, Hangzhou, Jiangxi
2024-05-21
Recruiting
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 1
152
Beijing, Guangzhou, Haerbin, Zhengzhou, Wuhan, Changsha, Jinan, Qingdao
2024-01-23
Recruiting
Tasly Pharmaceutical Group Co., Ltd
Phase 3
480
Beijing, Changsha, Chengdu, Haerbin, Huizhou, Kaifeng, Luoyang, Luzhou
2023-11-16
Not yet open
Fluorescence Laparoscopic Navigation for Rectal Cancer and Sigmoid Colon Cancer
NCT05730595Colorectal Neoplasms, Fluorescence, Lymph Node Excision
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Not applicable
550
Hefei, Beijing, Chengdu, Fuzhou, Guangzhou, Shijiazhuang, Haerbin, Nanjing
2023-09-01
Recruiting
A Study of BL-M11D1 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
NCT05924750Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1
130
Hefei, Beijing, Haerbin, Shenyang, Jinan, Shanghai, Chengdu, Tianjin
2023-08-02
Recruiting
Peijia Medical Technology (Suzhou) Co., Ltd.
Not applicable
116
Beijing, Fuzhou, Xiamen, Guangzhou, Guangdong, Haerbin, Wuhan, Changsha
2023-08-01
Active, closed
Jiangsu HengRui Medicine Co., Ltd.
Phase 3
213
Haerbin
2023-04-25
Recruiting
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1/2
40
Beijing, Haerbin, Qingdao
2022-09-26
Active, closed
Singlera Genomics Inc.
Observational
800
Beijing, Chengdu, Guangzhou, Haerbin, Shanghai, Shenzhen, Taiyuan
2022-06-20
Recruiting
Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors
NCT05024214Solid Tumors, Non-small Cell Lung Cancer, Renal Cell Carcinoma, Hepatocellular Carcinoma
3D Medicines (Sichuan) Co., Ltd.
Phase 1/2
170
Bengbu, Beijing, Fuzhou, Xiamen, Dongguan, Guangzhou, Zhuhai, Haerbin
2021-11-15
Recruiting
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
NCT04913285Solid Tumor, Adult, Non-small Cell Lung Cancer, Melanoma
Pierre Fabre Medicament
Phase 1
400
Haerbin, Linyi, Beijing, Shanghai
2021-08-04
Recruiting
Abbisko Therapeutics Co, Ltd
Phase 1
200
Bengbu, Beijing, Chongqing, Fuzhou, Guangzhou, Nanning, Weifang, Haerbin
2020-02-26
Active, closed
A Study to Compare Zolbetuximab (IMAB362) and Chemotherapy With Placebo and Chemotherapy in Adults With Gastric Cancer.
NCT03504397Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
Astellas Pharma Global Development, Inc.
Phase 3
565
Haerbin, Nanjing, Hangzhou, Beijing, Hefei, Xiamen, Zhengzhou
2018-06-21
Rows per page Showing 1–21 of 21
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 20 November 2026. https://priyalifescience.com/clinical-trials-china/city/haerbin

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,398 studies in total at the last sync on 20 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 21 of those studies with a site in Haerbin.

How many clinical trials are recruiting in Haerbin?

16 of the 21 studies on this page are recruiting new participants as of the 20 Nov 2026, 03:17 UTC sync. A further 1 have not yet opened recruitment, 4 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Haerbin), 21 studies
PhaseStudiesRecruitingShare
Phase 36428.6%
Phase 15523.8%
Phase 1/25523.8%
Not applicable3114.3%
Observational219.5%

Most active sponsors

Lead sponsors with the most studies (Haerbin)
Lead sponsorStudiesRecruiting
Jiangsu Simcere Pharmaceutical Co., Ltd.22
Sichuan Baili Pharmaceutical Co., Ltd.22
3D Medicines (Sichuan) Co., Ltd.11
4D Molecular Therapeutics11
Abbisko Therapeutics Co, Ltd11
Allist Pharmaceuticals, Inc.11
Astellas Pharma Global Development, Inc.10
AstraZeneca11
Cancer Institute and Hospital, Chinese Academy of Medical Sciences10
Daiichi Sankyo11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.